The Food and Drug Administration silenced one of its drug experts who raised safety concerns weeks before Merck & Co. yanked the blockbuster drug Vioxx due to increased risks for heart attack and strokes.
While patients need to stop taking Vioxx, local physicians said, it is not easy to decide on a new course of treatment.
So, he said, that information has come entirely from Merck and Celebrex.
